These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 8692721

  • 21. Modulation of myogenic differentiation in a human rhabdomyosarcoma cell line by a new derivative of 5-fluorouracil (QF-3602).
    Marchal JA, Melguizo C, Prados J, Aránega AE, Gómez JA, Campos J, Gallo MA, Espinosa A, Arena N, Aránega A.
    Jpn J Cancer Res; 2000 Sep; 91(9):934-40. PubMed ID: 11011122
    [Abstract] [Full Text] [Related]

  • 22. Therapy associated differentiation in rhabdomyosarcomas.
    d'Amore ES, Tollot M, Stracca-Pansa V, Menegon A, Meli S, Carli M, Ninfo V.
    Mod Pathol; 1994 Jan; 7(1):69-75. PubMed ID: 8159655
    [Abstract] [Full Text] [Related]

  • 23. Use of lipid vesicles as carriers to introduce actinomycin D into resistant tumor cells.
    Papahadjopoulos D, Poste G, Vail WJ, Biedler JL.
    Cancer Res; 1976 Sep; 36(9 pt.1):2988-94. PubMed ID: 975068
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Differentiation induction in the human rhabdomyosarcoma cell line TE-671. A morphological, biochemical and molecular analysis.
    Ramp U, Gerharz CD, Engers R, Marx N, Gabbert HE.
    Anticancer Res; 1995 Sep; 15(1):181-8. PubMed ID: 7733631
    [Abstract] [Full Text] [Related]

  • 31. Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD.
    Knudsen ES, Pazzagli C, Born TL, Bertolaet BL, Knudsen KE, Arden KC, Henry RR, Feramisco JR.
    Cancer Res; 1998 May 01; 58(9):2042-9. PubMed ID: 9581851
    [Abstract] [Full Text] [Related]

  • 32. Telomerase reverse transcriptase promoter regulation during myogenic differentiation of human RD rhabdomyosarcoma cells.
    Ma H, Urquidi V, Wong J, Kleeman J, Goodison S.
    Mol Cancer Res; 2003 Aug 01; 1(10):739-46. PubMed ID: 12939399
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Veno-occlusive disease in pediatric patients receiving actinomycin D and vincristine only for the treatment of rhabdomyosarcoma.
    Sulis ML, Bessmertny O, Granowetter L, Weiner M, Kelly KM.
    J Pediatr Hematol Oncol; 2004 Dec 01; 26(12):843-6. PubMed ID: 15591910
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.